The Epidemiology and Pathogenesis and Treatment of Pseudomonas aeruginosa Infections: An Update

D Reynolds, M Kollef - Drugs, 2021 - Springer
Pseudomonas aeruginosa is a Gram-negative bacterial pathogen that is a common cause of
nosocomial infections, particularly pneumonia, infection in immunocompromised hosts, and …

Bacterial biofilm formation on implantable devices and approaches to its treatment and prevention

Z Khatoon, CD McTiernan, EJ Suuronen, TF Mah… - Heliyon, 2018 - cell.com
In living organisms, biofilms are defined as complex communities of bacteria residing within
an exopolysaccharide matrix that adheres to a surface. In the clinic, they are typically the …

Inhaled amikacin to prevent ventilator-associated pneumonia

S Ehrmann, F Barbier, J Demiselle… - … England Journal of …, 2023 - Mass Medical Soc
Background Whether preventive inhaled antibiotics may reduce the incidence of ventilator-
associated pneumonia is unclear. Methods In this investigator-initiated, multicenter, double …

Antibiotic resistance in Pseudomonas aeruginosa–Mechanisms, epidemiology and evolution

J Botelho, F Grosso, L Peixe - Drug resistance updates, 2019 - Elsevier
Antibiotics are powerful drugs used in the treatment of bacterial infections. The inappropriate
use of these medicines has driven the dissemination of antibiotic resistance (AR) in most …

Bloodstream infections in critically ill patients: an expert statement

JF Timsit, E Ruppé, F Barbier, A Tabah… - Intensive care medicine, 2020 - Springer
Bloodstream infection (BSI) is defined by positive blood cultures in a patient with systemic
signs of infection and may be either secondary to a documented source or primary—that is …

Antimicrobial resistance of Pseudomonas aeruginosa: navigating clinical impacts, current resistance trends, and innovations in breaking therapies

A Elfadadny, RF Ragab, M AlHarbi, F Badshah… - Frontiers in …, 2024 - frontiersin.org
Pseudomonas aeruginosa, a Gram-negative bacterium, is recognized for its adaptability and
opportunistic nature. It poses a substantial challenge in clinical settings due to its …

Pseudomonas aeruginosa Lifestyle: A Paradigm for Adaptation, Survival, and Persistence

MF Moradali, S Ghods, BHA Rehm - Frontiers in cellular and infection …, 2017 - frontiersin.org
Pseudomonas aeruginosa is an opportunistic pathogen affecting immunocompromised
patients. It is known as the leading cause of morbidity and mortality in cystic fibrosis (CF) …

[CARTE][B] Global report on infection prevention and control

World Health Organization - 2022 - books.google.com
Page 1 + Clinical care Water, sanitation and hygiene Outbreak preparedness and response
Health system strengthening International health regulations Patient safety Quality …

Rationalizing antimicrobial therapy in the ICU: a narrative review

JF Timsit, M Bassetti, O Cremer, G Daikos… - Intensive care …, 2019 - Springer
The massive consumption of antibiotics in the ICU is responsible for substantial ecological
side effects that promote the dissemination of multidrug-resistant bacteria (MDRB) in this …

The impact of healthcare-associated infections on mortality in ICU: A prospective study in Asia, Africa, Eastern Europe, Latin America, and the Middle East

VD Rosenthal, R Yin, Y Lu, C Rodrigues… - American journal of …, 2023 - Elsevier
Background The International Nosocomial Infection Control Consortium has found a high
ICU mortality rate. Our aim was to identify all-cause mortality risk factors in ICU-patients …